Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells - PubMed (original) (raw)
Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells
G Penna et al. J Immunol. 2001.
Abstract
The existence of dendritic cell (DC) subsets is firmly established, but their trafficking properties are virtually unknown. In this study, we show that myeloid (M-DCs) and plasmacytoid (P-DCs) DCs isolated from human blood differ widely in the capacity to migrate to chemotactic stimuli. The pattern of chemokine receptors expressed by blood M-DCs and P-DCs, with the exception of CCR7, is similar. However, most chemokine receptors of P-DCs, in particular those specific for inflammatory chemokines and classical chemotactic agonists, are not functional in circulating cells. Following maturation induced by CD40 ligation, the receptors for inflammatory chemokines are down-regulated, and CCR7 on P-DCs becomes coupled to migration. The drastically impaired capacity of blood P-DCs to migrate in response to inflammatory chemotactic signals contrasts with the response to lymph node-homing chemokines, indicating a propensity to migrate to secondary lymphoid organs rather than to sites of inflammation.
Similar articles
- Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells.
Penna G, Vulcano M, Sozzani S, Adorini L. Penna G, et al. Hum Immunol. 2002 Dec;63(12):1164-71. doi: 10.1016/s0198-8859(02)00755-3. Hum Immunol. 2002. PMID: 12480260 Review. - Mammalian and viral IL-10 enhance C-C chemokine receptor 5 but down-regulate C-C chemokine receptor 7 expression by myeloid dendritic cells: impact on chemotactic responses and in vivo homing ability.
Takayama T, Morelli AE, Onai N, Hirao M, Matsushima K, Tahara H, Thomson AW. Takayama T, et al. J Immunol. 2001 Jun 15;166(12):7136-43. doi: 10.4049/jimmunol.166.12.7136. J Immunol. 2001. PMID: 11390459 - Expression of a functional eotaxin (CC chemokine ligand 11) receptor CCR3 by human dendritic cells.
Beaulieu S, Robbiani DF, Du X, Rodrigues E, Ignatius R, Wei Y, Ponath P, Young JW, Pope M, Steinman RM, Mojsov S. Beaulieu S, et al. J Immunol. 2002 Sep 15;169(6):2925-36. doi: 10.4049/jimmunol.169.6.2925. J Immunol. 2002. PMID: 12218106 - Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin.
Vermi W, Riboldi E, Wittamer V, Gentili F, Luini W, Marrelli S, Vecchi A, Franssen JD, Communi D, Massardi L, Sironi M, Mantovani A, Parmentier M, Facchetti F, Sozzani S. Vermi W, et al. J Exp Med. 2005 Feb 21;201(4):509-15. doi: 10.1084/jem.20041310. J Exp Med. 2005. PMID: 15728234 Free PMC article. - Dendritic cells, chemokine receptors and autoimmune inflammatory diseases.
Cravens PD, Lipsky PE. Cravens PD, et al. Immunol Cell Biol. 2002 Oct;80(5):497-505. doi: 10.1046/j.1440-1711.2002.01118.x. Immunol Cell Biol. 2002. PMID: 12225387 Review.
Cited by
- Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling.
Monti M, Ferrari G, Gazzurelli L, Bugatti M, Facchetti F, Vermi W. Monti M, et al. J Exp Clin Cancer Res. 2024 Jul 17;43(1):196. doi: 10.1186/s13046-024-03121-9. J Exp Clin Cancer Res. 2024. PMID: 39020402 Free PMC article. Review. - The Multifaceted Functionality of Plasmacytoid Dendritic Cells in Gastrointestinal Cancers: A Potential Therapeutic Target?
Hansen FJ, David P, Weber GF. Hansen FJ, et al. Cancers (Basel). 2024 Jun 13;16(12):2216. doi: 10.3390/cancers16122216. Cancers (Basel). 2024. PMID: 38927922 Free PMC article. Review. - Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer.
Tiberio L, Laffranchi M, Zucchi G, Salvi V, Schioppa T, Sozzani S, Del Prete A, Bosisio D. Tiberio L, et al. Front Immunol. 2024 Mar 5;15:1360291. doi: 10.3389/fimmu.2024.1360291. eCollection 2024. Front Immunol. 2024. PMID: 38504978 Free PMC article. Review. - Targeting CXCL9/10/11-CXCR3 axis: an important component of tumor-promoting and antitumor immunity.
Pan M, Wei X, Xiang X, Liu Y, Zhou Q, Yang W. Pan M, et al. Clin Transl Oncol. 2023 Aug;25(8):2306-2320. doi: 10.1007/s12094-023-03126-4. Epub 2023 Apr 19. Clin Transl Oncol. 2023. PMID: 37076663 Review. - The role of CXCR3 and its ligands in cancer.
Wang X, Zhang Y, Wang S, Ni H, Zhao P, Chen G, Xu B, Yuan L. Wang X, et al. Front Oncol. 2022 Nov 21;12:1022688. doi: 10.3389/fonc.2022.1022688. eCollection 2022. Front Oncol. 2022. PMID: 36479091 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials